GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Piramal Pharma Ltd
Piramal Pharma Board to Convene October 27 for Q2 FY27 Financial Results
RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 16 Oct 2026, 12:11 PM IST  ·  BSE ID: 13cd0e1c-8e52-4cec-bd9d-a9cf0465815d
View Original BSE Filing (PDF)
💡
In Simple Terms
Piramal Pharma will announce its financial results for July-September 2026 on October 27, 2026.
🤖 AI Summary
  • Piramal Pharma's Board of Directors will convene on Tuesday, October 27, 2026.
  • The board meeting is scheduled to consider and approve Unaudited Financial Results.
  • Results include standalone and consolidated data for Q2 FY27 and half year ended September 30, 2026.
  • Trading window for company securities closed October 1, 2026, till October 29, 2026.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this intimation.
👤
Who Is Affected
All shareholders of Piramal Pharma Ltd are indirectly affected by the upcoming financial results, which will provide an update on the company's performance.
🔍
Management Signal
The scheduled board meeting indicates management adherence to regulatory timelines for financial disclosures and corporate governance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Piramal Pharma's Q2 FY27 Unaudited Financial Results on October 27, 2026.
Detailed analysis of standalone and consolidated performance for Q2 FY27.
Trading window re-opening on October 30, 2026.
LOW RISK This filing is a routine board meeting intimation, carrying no inherent business or financial risks.
💡 Investor Takeaway
Piramal Pharma Ltd. board will meet on October 27, 2026, to approve its Unaudited Financial Results for the quarter and half year ended September 30, 2026. This is a routine regulatory update.
📅 Company Track Record
Piramal Pharma Ltd reported Q1 FY27 standalone revenue of Rs. 1,124.95 Crores, representing a 16.0% YoY increase, as per filing dated July 29, 2026.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is Piramal Pharma Ltd's board meeting scheduled?
Piramal Pharma Ltd's Board of Directors meeting is scheduled for Tuesday, October 27, 2026.
What is the primary agenda of the Piramal Pharma board meeting on October 27, 2026?
The primary agenda is to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026.
When does the trading window for Piramal Pharma Ltd securities close and re-open?
The trading window for Piramal Pharma Ltd securities closed on Thursday, October 1, 2026, and will remain closed until Thursday, October 29, 2026 (both days inclusive).

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.